DOI: 10.1016/j.jfluchem.2018.12.005
Researchers from the Department of Medicinal Chemistry at The University of Kansas have made a significant breakthrough in the field of peptide chemistry with the successful synthesis of Leu-enkephalin peptidomimetics containing trifluoromethylalkenes. Their groundbreaking work, recently published in the Journal of Fluorine Chemistry, has promising implications for both the medical and biotechnological applications of peptide-based compounds.
Introduction
Peptides play an incredible role in biological processes, acting as hormones, neurotransmitters, and as molecules that control cell proliferation, differentiation, and other critical functions. Mimicking the structure and activity of peptides through peptidomimetics allows for greater understanding and control over these processes and has significant therapeutic potential. Despite the promise, challenges remain, including peptide stability and the optimal incorporation of fluorinated residues that can significantly alter the chemical and physical properties of these molecules.
The Challenge
A trifluoromethyl group, when incorporated into organic molecules, can modulate properties like metabolic stability and lipophilicity. This makes trifluoromethylalkenes, with their ability to serve as amide isopolar mimics, of particular interest. However, their integration into peptides has been problematic due to isomerization under common peptide-coupling conditions. The effort to embed these moieties into peptide chains without altering the desired spatial orientation is a key challenge researchers have been facing.
The Approach
To overcome these synthetic challenges, the team led by Drs. Venkateswararao Eeda, Manikandan Selvaraju, and Ryan A. Altman focused on developing a method to include trifluoromethylalkenes as isopolar amide mimics in peptidomimetics without isomerization. They modified the amino acid tyrosine, a natural component of peptides, to include a trifluoromethylalkene. By doing so, they preserved the geometry and electronic characteristics essential for the biological activity of Leu-enkephalin, an opioid peptide with important roles in pain regulation and opioid addiction.
Results
The researchers successfully demonstrated the synthesis of modified Leu-enkephalin peptidomimetics. Their method effectively prevented the undesired isomerization of the trifluoromethylalkene moiety, which was verified by comprehensive conformational and geometrical analyses. Moreover, the introduced trifluoromethylalkenes showed potential as isopolar mimics of the amide bond, a trait that could be beneficial in enhancing the membrane permeability and metabolic stability of peptide-based drugs.
Potential Impact
This work has important implications for drug discovery and the development of new therapeutic agents. Fluorinated peptidomimetics with improved properties such as enhanced blood-brain barrier permeability, resistance to enzymatic degradation, and better bioavailability have great therapeutic potential. The ability to fine-tune the physicochemical properties of peptide-based probes without compromising their biological function makes these trifluoromethyl-containing peptidomimetics valuable tools for biological research and pharmaceutical development.
References
1. Luca G, Alessandra T, Federico S, Peptides, and peptidomimetics in medicine, surgery, and biotechnology, Curr. Med. Chem 13 (2006) 2449–2466.
2. Cornford EM, Braun LD, Crane PD, Oldendorf WH, Blood-Brain Barrier Restriction of Peptides and the Low Uptake of Enkephalins*, Endocrinology. 103 (1978) 1297–1303.
3. Roques BP, Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction, NIDA Res Monogr 147 (1995) 104–145.
4. Wipf P, Henninger TC, Geib SJ, Methyl- and (trifluoromethyl)alkene peptide isosteres: Synthesis and evaluation of their potential as β-Turn promoters and peptide mimetics, J. Org. Chem 63 (1998) 6088–6089.
5. Molteni M, Bellucci MC, Bigotti S, Mazzini S, Volonterio A, Zanda M, Ψ[CH(CF3)NH]Gly-peptides: synthesis and conformation analysis, Org. Biomol. Chem 7 (2009) 2286–2296.
Keywords
1. Trifluoromethylalkene Peptidomimetics
2. Leu-Enkephalin Synthesis
3. Fluorinated Peptide Mimics
4. Opioid Peptides Drug Design
5. Amide Isopolar Mimics Chemistry
In summary, the reported novel methodology for the synthesis of Leu-enkephalin peptidomimetics containing trifluoromethylalkenes as amide isopolar mimics offers great prospects for the development of new, more effective therapeutic options. This approach can pave the way for future breakthroughs in peptide-based drug development and potentially life-changing treatments for patients suffering from pain and addiction, demonstrating the critical interplay between chemical innovation and therapeutic advancement.